When was Multiply Labs founded?

Multiply Labs was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is Multiply Labs located?

Multiply Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California.

Who is the current CEO of Multiply Labs?

Fred Parietti of Multiply Labs. They have also founded 1 company.

How many employees does Multiply Labs have?

As of Aug 31, 2026, the latest employee count at Multiply Labs is 77.

Is Multiply Labs a funded company?

Multiply Labs is a funded company, having raised a total of $41.3M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 20, 2016.

How much is Multiply Labs worth?

The latest valuation of Multiply Labs is $***** as of Aug 22, 2016. This marks a decline of 1% from its peak valuation of $1.71M in Aug, 2016. This marks a decline of 1% from its peak valuation of $1.71M in Aug, 2016.

When was the latest funding round of Multiply Labs?

Multiply Labs' latest funding was a $***** Series A round on Apr 21, 2023, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.29B in funding in 2026 to date.

Where does Multiply Labs rank among its competitors?

Multiply Labs ranks 1st amongst 34 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $50M in Jun, 2026.

Who are the top competitors of Multiply Labs?

Multiply Labs' top competitors include Oribiotech, Cellares and Cellular Origins. Among them, Cellares secured the most recent funding round in June, 2026.

Multiply Labs - 2026 Company Profile, Team, Funding & Competitors

Multiply Labs is a series A company based in San Francisco (United States), founded in 2016 by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson. It operates as a Manufacturer of precision medicines through innovative robotic technology. Multiply Labs has raised $41.3M in funding from investors like Y Combinator, Casdin Capital and P101, with a current valuation of $*****. The company has 34 active competitors, including 10 funded and 2 that have exited. Its top competitors include companies like Oribiotech, Cellares and Cellular Origins.

Company Details

Manufacturer of precision medicines through innovative robotic technology. The company is offering Robotic systems to manufacture gene modified cell therapies at industrial scale. It also, offer a Digital QC an automation software that enables process planning and digital records.

Website: multiplylabs.com
Social
Email ID: *****@multiplylabs.com
Registered Address: San Francisco, California

Key Metrics

Founded Year

2016

Location

San Francisco, United States

Stage

Series A

Total Funding

$41.3M in 7 rounds

Latest Funding Round

Series A, Apr 21, 2023, $*****

Post Money Valuation

$***** as on Aug 22, 2016

Investors

Y Combinator & 23 more

Ranked

1^st among 34 active competitors

Employee Count

77 as on Aug 31, 2026

Similar Companies

Oribiotech & 33 more

View Multiply Labs' full profile

Multiply Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MULTIPLY LABS, INC. CIN: 812483725 , United States, Active	Dec 31, 1999	-	34 (As on Dec 31, 2024)	-

Multiply Labs has raised a total funding of $41.3M over 7 rounds. Its first funding round was on Aug 20, 2016. Multiply Labs has 24 institutional investors.

Here is the list of recent funding rounds of Multiply Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 21, 2023	8959209	Series A	1019157	8611656	4011693	8117866
Apr 14, 2021	9134844	Series A	4512391	9420954	4467626	Lux Capital & 3 more
Oct 27, 2018	1573044	Series A	2983141	6488572	5504894	6897685

Access funding benchmarks and valuations. Sign up today!

View details of Multiply Labs's funding rounds and investors

The founders of Multiply Labs are Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson. Fred Parietti is the CEO of Multiply Labs.

Here are the details of Multiply Labs' key team members:

Alice Melocchi: Co-Founder & CSO of Multiply Labs. They serve on the board of 1 company.
Contact Info: 1 email address
Tiffany Kuo: Co-Founder of Multiply Labs. They serve on the board of 1 company.
Fred Parietti: Co-Founder & CEO of Multiply Labs.
Contact Info: 1 email address
Joe Wilson: Former Co-Founder of Multiply Labs.

Multiply Labs' Board of Directors

Multiply Labs's board has 8 active members. Alice Melocchi, Tiffany Kuo, Michael Doherty, Krishnan Viswanadhan, Joseph Siener Wilson, Federico Parietti, Jason Arcediano and Shaun Rodriguez are independent board members.

Here is the list of Multiply Labs' board of directors:

Name	Type	Representing	Status	Duration
Alice Melocchi	Independent board member	-	Current	9y 4m
mtczatl	Independent board member	-	Current	7y 9m
ibaundp	Independent board member	-	Current	6y 3m
csocbfe	Independent board member	-	Current	5y 4m
pdmrsiy	Independent board member	-	Current	6y 7m
{m{uebp	Independent board member	-	Current	7y 9m
oixtsgk	Independent board member	-	Current	4y 3m
cc{bkxf	Independent board member	-	Current	9y 1m

View details of Multiply Labs's Founder profiles and Board Members

Multiply Labs' employee count trend

Multiply Labs has 77 employees as of Aug 26. Here is Multiply Labs's employee count trend over the years:

Uncover Multiply Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Multiply Labs include Oribiotech, Cellares and Cellular Origins. Here is the list of Top 10 competitors of Multiply Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Graph Ventures, Pegasus Tech Ventures & 22 others	69/100
2nd	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Northpond Ventures, Novalis LifeSciences ... & 17 others	66/100
3rd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$682M	Eclipse, Decheng Capital & 17 others	64/100
4th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	55/100
5th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, EIC Fund & 5 others	55/100
6th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.45M	Acequia Capital, Climate Capital & 9 others	44/100
7th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 4 others	40/100
8th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	40/100
9th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners, Asia2G Capital	39/100
10th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Innovation Works, Denniston Family Office ... & 2 others	35/100